欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

Metabolic Disease

货号 产品名 CAS号 信息
CSN19930 8-(((2S,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one 76135-82-5 Vitexin-4″-O-Glucoside can inhibit TPO activity. It is a natural product isolated and purified from the fruit of Crataegus pinnatifida Bge.
CSN18446 JNJ-17203212 821768-06-3 JNJ-17203212 is a selective TRPV1 antagonist, with IC50 of 65 nM and 102 nM for human TRPV1 and rat TRPV1.
CSN18618 BMS-303141 943962-47-8 BMS-303141 is a potent ATPcitrate lyase (ACL) inhibitor with IC50 of 0.13 μM (human recombinant ACL).
CSN19073 AS1842856 836620-48-5 AS-1842856 is a potent inhibitor of forkhead box class O transcription factor 1 (Foxo1) with IC50 of 33 nM in HepG2 cells which directly bind to the active Foxo1.
CSN19427 Rimonabant 168273-06-1 Rimonabant is a selective central cannabinoid (CB1) receptor inverse agonist with Ki of 1.8 nM.
CSN19437 Topiroxostat 577778-58-6 Topiroxostat is an inhibitor of xanthine oxidoreductase (XOR) with IC50 of 5.3 nM.
CSN18543 APD597 897732-93-3 APD597 is an agonist of GPR119 with EC50 of 46 nM and is used for the treatment of type 2 diabetes.
CSN19742 Idazoxan HCl 79944-56-2 Idazoxan is an alpha2-adrenoceptor antagonist potentially for the treatment of schizophrenia.
CSN19378 Prostaglandin E1 745-65-3 Alprostadil is an analog of prostaglandin which is prostaglandin E1 agonist with vasodilatory properties and can be used to treat erectile dysfunction.
CSN20010 2-Hydroxy-4-isopropylcyclohepta-2,4,6-trien-1-one 499-44-5 Hinokitiol, an iron chelator originally extracted from woods of Thuja plicata and Chamaecyparis obtuse, has been found to inhibit ultraviolet B-induced apoptosis in keratinocytes of murine ear skin via antioxidant activity of metallothionein. It can partially mimic the function of missing protein transporters of iron, and possibly other ions, may have potential in treating human diseases.
CSN19726 4-(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile hydrochloride 102676-31-3 Fadrozole HCl specifically inhibits aromatase, blocking the aromatization of androstenedione and testosterone into estrone and estradiol, respectively.
CSN19255 SR-18292 2095432-55-4 SR-18292 is a potential molecule with inhibition of PGC-1α gluconeogenic activity for treating diabetes by reducing blood glucose, strongly increases hepatic insulin sensitivity and improving glucose homeostasis in dietary and genetic mouse models of T2D.
CSN19442 Alverine citrate 5560-59-8 Alverine Citrate is a 5-HT1A receptor antagonist with IC50 value of 101 nM.
CSN18725 Rbin-1 328023-11-6 Rbin-1 inhibits ATPase with GI50 of 136±7 nM, it is a potent, reversible, and specific chemical inhibitor of eukaryotic ribosome biogenesis.
CSN20033 CL 316243 138908-40-4 CL-316243 is a potent and highly selective β3-adrenoceptor agonist (EC50 = 3 nM) and > 10000-fold selective over β1 and β2 receptors. CL-316243 restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice.
CSN19257 LMPTP inhibitor 1 1908414-82-3 LMPTP inhibitor 1 is a potent molecule for diabetes which can increase liver IR phosphorylation in vivo and reverses high-fat diet-induced diabetes by inhibiting the IR phosphatase LMPTP.
CSN19904 Neomangiferin 64809-67-2 Neomangiferin, a natural product isolated and purified from the herbs of Mangifera indica L. with beneficial effects on high fat diet-induced nonalcoholic fatty liver disease in rats, and inhibits tartrate-resistant acid phosphatase, a biochemical marker of osteoclast function and bone resorption.
CSN19379 3-Hydroxy-3-methylpentanedioic acid 503-49-1 Meglutol is an antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids, and inhibits the activity of hydroxymethylglutarryl CoA reductases, which is the rate limiting enzyme in the biosynthesis of cholesterol.
CSN19126 Emixustat 1141777-14-1 Emixustat, a visual cycle modulator, is an inhibitor of thevisual cycle isomerasewith an IC50 value of 4.4 nMin vitro.
CSN18945 pemafibrate 848259-27-8 Pemafibrateis a selective PPARα modulator (SPPARMα) that has antihyperlipidaemic activity.
CSN18596 (1R,3S,Z)-5-(2-((1R,3aS,7aR,E)-1-((2R,5R)-5-Hydroxy-6-methylheptan-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol hydrate 93129-94-3 Tacalcitol promotes normal bone development by regulating calcium.
CSN18429 Imeglimin HCl 775351-61-6 Imeglimin HCl is the first in a tetrahydrotriazine-containing class of oral antidiabetic agents, the glimins.
CSN18972 Taranabant ((1R,2R)stereoisomer) 701977-08-4 Taranabant(1R,2R)stereoisomer is the R-Enantiomer of taranabant. Taranabant is a highly potent and selective cannabinoid 1 (CB1) receptor inverse agonist.
CSN18992 Taspoglutide 275371-94-3 Taspoglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist developed for treatment of type 2 diabetes, with an EC50 value of 0.06 nM.
CSN19100 TCS 401 243966-09-8 TCS 401 is a selective inhibitor of protein tyrosine phosphatase 1B (PTP1B).
CSN18404 Calcitetrol 72203-93-1 Calcitetrol is the hormonally active form of vitamin D with three hydroxyl groups.
CSN18568 Exendin-4 acetate 914454-01-6 Exendin-4 acetate is a 39 amino acid peptide, activates GLP-1 (glucagon-like peptide-1) receptors to increase intracellular cAMP in pancreatic acinar cells and has no effect on VIP receptors.
CSN19866 Exendin-4 141758-74-9 Exendin-4 is a high affinity glucagon-like peptide 1 (GLP-1) receptor agonist (Kd = 136 pM) and originally isolated from Heloderma suspectum venom.
CSN19044 CDD3505 173865-33-3 CDD3505 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepaticcytochrome P450IIIA (CYP3A)activity.
CSN18617 Genz-123346 943344-58-9 Genz-123346 is an inhibitor of GL1 synthase that blocks the conversion of ceramide to GL1 and its IC50 for GM1 inhibition is 14 nM.
CSN19045 CDD3506 197913-15-8 CDD3506 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepaticcytochrome P450IIIA (CYP3A)activity.
CSN19036 SR12813 126411-39-0 SR-12813 is a pregnane X receptor (PXR) agonist and HMG-CoA reductase inhibitor with an IC50 of 850 nM.
CSN18790 Calcium (S)-2-benzyl-4-((3aR,7aS)-octahydro-2H-isoindol-2-yl)-4-oxobutanoate dihydrate 207844-01-7 Mitiglinide calcium is a drug for the treatment of type 2 diabetes and it is a highly selective KATP channel antagonist.
CSN18480 PF-915275 857290-04-1 PF-915275 is a potent and selective inhibitor of human 11β-hydroxysteroid dehydrogenase type 1(11βHSD1) (Ki < 1 nM) with good preclinical pharmacokinetic properties.
CSN18497 AMG 837 sodium salt 865231-45-4 AMG-837 sodium is a potent GPR40 agonist (EC50=13 nM) with a superior pharmacokinetic profile and robust glucose-dependent stimulation of insulin secretion in rodents.
CSN18946 Pemafibrate racemate 848258-31-1 Pemafibrate racemate is a selective PPARα modulator (SPPARMα).
CSN19699 AC-55649 59662-49-6 AC55649 is an agonist of the retinoic acid receptor β (RAR-β).
CSN18755 24, 25-Dihydroxy VD3 40013-87-4 24, 25-Dihydroxy VD3 is a compound which is closely related to 1,25-dihydroxyvitamin D3, the active form of vitamin D3, but like vitamin D3 itself and 25-hydroxyvitamin D3 is inactive as a hormone both in vitro and in vivo.
CSN18405 ZLN024 723249-01-2 ZLN024 is an AMPK allosteric activator and activates α1β1γ1 and α2β1γ1 by around 2–2.5 fold with an EC50 of about 1–2 μM.
CSN18969 ZLN024 HCl 1883548-91-1 ZLN024 HCl is an AMPK allosteric activator and activates α1β1γ1 and α2β1γ1 by around 2–2.5 fold with an EC50 of about 1–2 μM.
CSN18988 GRA Ex-25 307983-31-9 GRA Ex-25 is an inhibitor of glucagon receptor, with IC50 of 56 and 55 nM for rat and human glucagon receptors, respectively.
CSN19038 AM-2394 1442684-77-6 AM-2394 is a structurally distinct glucokinase activator (GKA). AM-2394 activates glucokinase (GK) with an EC50 of 60 nM.
CSN19739 LX2761 1610954-97-6 LX2761 is a locally acting SGLT1 inhibitor that is highly potent in vitro and delays intestinal glucose absorption in vivo to improve glycemic control. LX2761 was designed to remain in the intestine after oral delivery to inhibit SGLT1 locally without affecting the SGLT1/2 mechanism in the kidney.
CSN19747 BI-135585 1114561-85-1 BI-135585 is a potent and selective 11β-HSD1 inhibitor for treating Type 2 diabetes.
CSN19749 Zy15557 1601480-12-9 ZY15557 is a potent, competitive and long acting DPP-4 inhibitor showing similar DPP-4 inhibition across different species.
<< PREV 1 2 3 4 5 6 7 8 9 NEXT >>
联系
我们